Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Common antidepressant slashes risk of COVID death, study says

Fluvoxamine is both inexpensive and highly effective at preventing mild COVID-19 from turning severe.
By
  1. Saima May Sidik

A cheap, widely available drug used to treat mental illness cuts both the risk of death from COVID-19 and the need for people with the disease to receive intensive medical care, according to clinical-trial results1.

Access options

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-021-02988-4

References

  1. Reis, G. et al. Lancet Glob. Health https://doi.org/10.1016/S2214-109X(21)00448-4 (2021).

    Article  Google Scholar 

  2. Rosen, D. A. et al. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aau5266 (2019).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links